New research published in July 2026 by Professor Yoshiro Saito and Elena Kalinina expands the understanding of ferroptosis, an iron-dependent cell death process. While glutathione peroxidase 4 (GPX4) is a key selenium-dependent defender against lipid peroxidation, a broader selenium metabolic network and enzymes like ChaC1 and GSTs dynamically regulate glutathione levels and redox balance. Manipulating these pathways offers promising strategies to selectively induce ferroptosis in cancer cells while protecting healthy tissues.
Glutathione ferroptosis regulation
- ▪Glutathione is a cellular non-enzymatic antioxidant synthesized at concentrations of 1 to 5 millimolar, existing primarily in its reduced form under normal conditions.
- ▪The ratio between reduced and oxidized glutathione is maintained by glutathione reductase to support cellular redox potential and thermodynamic equilibrium.
GPx4 lipid peroxide reduction
- ▪Selenium deficiency reshapes the selenoprotein network through hierarchical regulation of selenoprotein synthesis, altered selenium transport, and metabolic adaptation.
- ▪Glutathione peroxidase 4 is a selenium-containing enzyme that reduces lipid hydroperoxides to suppress ferroptosis, an iron-dependent form of regulated cell death.
ChaC1 GSH degradation
- ▪Glutathione-specific gamma-glutamyl cyclotransferases catalyze intracellular glutathione degradation, which directly affects cellular redox status and cell viability.
- ▪Glutathione-specific gamma-glutamyl cyclotransferase 1 degrades intracellular glutathione, which can induce ferroptosis, particularly during excessive endoplasmic reticulum stress.
GST antioxidant defense
- ▪Glutathione S-transferases and glutathione peroxidases support cellular redox homeostasis by limiting reactive oxygen species to tumor-promoting levels.
- ▪Glutathione S-transferases utilize glutathione as a co-substrate to reduce hydroperoxides to alcohols, defending cells against increased oxidative stress.
Ferroptosis cancer therapy
- ▪Inducing ferroptosis in cancer cells with inducers while protecting healthy tissues with inhibitors represents an effective pathway for targeted tumor treatments.
- ▪Manipulating selenium metabolism provides opportunities to fine-tune ferroptosis sensitivity, potentially enhancing ferroptosis in cancer cells to improve anti-tumor therapies.
Story comments
Loading comments…